Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126096861 | 12609686 | 1 | I | 20160711 | 20160801 | 20160801 | EXP | CN-ROCHE-1793061 | ROCHE | QU Y, SAIFUDING K AND TANG Y. EFFICACY AND SAFETY OF BEVACIZUMAB COMBINED WITH CHEMOTHERAPY IN TREATMENT OF METASTATIC COLORECTAL CANCER. WORLD CHINESE JOURNAL OF DIGESTOLOGY 2016 JUN 18;24(17):2748-2754. | 0.00 | Y | 0.00000 | 20160801 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126096861 | 12609686 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | ||||||||||
| 126096861 | 12609686 | 2 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | ||||||||||
| 126096861 | 12609686 | 3 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 0 | ||||||||||
| 126096861 | 12609686 | 4 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Unknown | U | 0 | ||||||||||
| 126096861 | 12609686 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | U | 0 | ||||||||||
| 126096861 | 12609686 | 6 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126096861 | 12609686 | 1 | Colorectal cancer metastatic |
| 126096861 | 12609686 | 2 | Colorectal cancer metastatic |
| 126096861 | 12609686 | 3 | Colorectal cancer metastatic |
| 126096861 | 12609686 | 4 | Colorectal cancer metastatic |
| 126096861 | 12609686 | 5 | Colorectal cancer metastatic |
| 126096861 | 12609686 | 6 | Colorectal cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126096861 | 12609686 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126096861 | 12609686 | Bone marrow failure | |
| 126096861 | 12609686 | Cardiac failure | |
| 126096861 | 12609686 | Diarrhoea | |
| 126096861 | 12609686 | Fatigue | |
| 126096861 | 12609686 | Haemorrhage | |
| 126096861 | 12609686 | Hypertension | |
| 126096861 | 12609686 | Nausea | |
| 126096861 | 12609686 | Neurotoxicity | |
| 126096861 | 12609686 | Palmar-plantar erythrodysaesthesia syndrome | |
| 126096861 | 12609686 | Proteinuria | |
| 126096861 | 12609686 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |